Mednet Logo
SpecialtiesNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you approach treatment of a glioblastoma in pregnancy?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

Glioblastoma during pregnancy could be treated safely (to mother and fetus) with certain precautions and modifications. Collaboration and consultation with the patient’s obstetrician are essential. External shielding over the patient’s abdomen during treatment will decrease the external scatter radi...

How do you manage patients with atrial fibrillation having a thromboembolic infarct despite being on adequate anticoagulation?

11
4 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

This scenario is always challenging. In terms of anticoagulation, the efficacy of DOACs in preventing embolic events in AF patients is around 70%, which is impressive compared to warfarin but not foolproof. In cases of a second embolic event while on anticoagulation, two reasonable approaches are of...

How do you evaluate for improvement in tremor from FUS in essential tremor?

1 Answers

Mednet Member
Mednet Member
Neurosurgery · Brigham and Women's Hospital

The best method for assessment of improvement in tremor after a FUS thalamotomy is by using a standardized clinical rating scale. These include the Essential Tremor Rating Scale (TETRAS) or the Clinical Rating Scale for Tremor (also known as the Fahn-Tolosa-Marin (FTM) score). The TETRAS scale has 2...

When would you prescribe pharmacologic DVT prophylaxis in bedbound neuromuscular patients?

1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Short answer: I would still not prescribe pharmacologic DVT prophylaxis routinely for all my bedbound neuromuscular patients in the outpatient setting. The point raised by the question is more than reasonable. Ideally, a randomized trial of prophylaxis vs. placebo should occur before we change our p...

When treating trigeminal neuralgia with SRS, are there vascular constraints or concern for late aneurysm?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

The incidence of cerebral aneurysms after stereotactic radiosurgery (SRS) for trigeminal neuralgia (TGN) is extremely rare. High-dose radiation (60 - 90 Gy) delivered to local microvasculature can theoretically cause focal vessel wall weakening, elastin degeneration, or radiation angiopathy leading ...

Do you treat migraine with aura if there is not an associated headache/pain?

1
3 Answers

Mednet Member
Mednet Member
Neurology · UPMC

I do if it interferes with quality of life. I do not recommend abortive medications for aura. There is no evidence that migraine abortive treatments shorten the duration of aura. I do not think that they do. Anecdotally, I have had some patients report that taking NSAIDs or a triptan at the aura ons...

What pharmacological management do you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?

14
3 Answers

Mednet Member
Mednet Member
Psychiatry · Center for Collaborative Parenting

As with all of my child patients, my approach is never to medicate behavior but rather to medicate suffering. This means that I view “aggression” of all forms as a kind of communication that something is wrong inside and that other means of effective communicating or managing that discomfort or what...

When is air travel safe for patients with recent diagnosis of ischemic stroke?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

Air travel on a modern commercial jet includes full pressurization and oxygenation, such that I see minimal or no risk to air travel. Flying on a small, private plane would have higher risk, so I would wait longer for that, perhaps even a month. During helicopter flights for acute stroke patients, o...

How do you treat steroid-refractory MS flares when PLEX is unavailable?

4 Answers

Mednet Member
Mednet Member
Neurology · Yale University School of Medicine

There is limited evidence on the efficacy of IVIG for MS relapses. A repeat course of IV methylprednisolone within 2-3 weeks could be considered. If the patient is not already on high-efficacy DMT, then I would also promptly initiate anti-CD20 therapy.

Should mRS be incorporated into determining eligibility for extended window thrombolysis?

2 Answers

Mednet Member
Mednet Member
Neurology · University of Virginia, School of Medicine

Key thrombolysis trials (WAKE UP, OPTION, EXTEND, TIMELESS, ECASS-4, HOPE, EXTEND IA) excluded patients with mRS of 2 or greater. The reason for this was the outcome of functional independence at 90 days. Hence, for trial purposes, to look at the outcome, it was necessary to exclude patients with di...